Shalabh Gupta, Md work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Shalabh Gupta, Md personal email
- Valid
- Valid
Shalabh Gupta, Md phone numbers
I firmly believe that, as human beings, we have a choice, and we can make a big difference by doing one small thing at a time. I am privileged to run a company where my fantastic team, with the support of our partners and investors, is developing the medicines that our patients need so badly.Bio:Shalabh Gupta, MD, founded Unicycive and has served as Chief Executive Officer, President, and director since August 2016. Previously, Dr. Gupta served in various other roles, including founder and Chief Executive Officer of Biocycive Inc.; a commercial strategist at Genentech, Inc.; equity researcher covering US pharmaceutical companies at UBS Investment Bank; and as an equity researcher covering biotechnology companies at Rodman & Renshaw (currently HC Wainwright). Dr. Gupta previously served as a medical advisor to Synageva BioPharma Corporation and as an advisor to New York University (NYU) Langone Medical Center’s Office of Technology Transfer. Dr. Gupta is also the founder and Chief Executive Officer of Globavir, a company with a diagnostic platform technology licensed from Stanford University, which partnered with Bio-Rad (NASDAQ: BIO) in 2016 and later with Cepheid (now part of Danaher Corporation, NYSE: DHR). Bio-Rad currently sells this technology as part of its RUO (Research Use Only) kits, and Danaher is advancing diagnostic technology through the regulatory approval process worldwide. Dr. Gupta is an advisor to the UCSF Innovation Center, a role he has held since 2020. Since 2012, Dr. Gupta has also been an advisor to SPARK, Stanford University School of Medicine. Dr. Gupta previously served on the Beall Center for Innovation and Entrepreneurship board of directors at the Paul Merage School of Business, University of California Irvine. Before his roles in business and finance, Dr. Gupta was an attending physician at New York University (“NYU”) Medical Center and a clinical faculty member at the NYU School of Medicine. Dr. Gupta was a board-certified physician currently licensed by the California State Medical Board. Dr. Gupta completed his internship in Internal Medicine, medical residency in Physical Medicine and Rehabilitation, and research fellowship in Cardiopulmonary Rehabilitation at NYU School of Medicine. Dr. Gupta received his MPA in Health Care Finance and Management from NYU’s Robert F. Wagner Graduate School of Public Service and his MD from Jawaharlal Institute of Postgraduate Medical Education & Research, India.Dr. Gupta has been in several leadership roles throughout his academic and professional career.
-
Founder, Chairman And CeoUnicycive Therapeutics 2016 - PresentLos Altos, Ca, UsFounded the company from scratch in August 2016 and took the company public on Nasdaq in July 2021.Please visit unicycive.com for all the details. -
Founder, Chairman And CeoGlobavir Biosciences, Inc. Sep 2013 - PresentFounded the company to advance technologies developed at the Stanford University School of Medicine as part of the SPARK program to advance new innovative technologies to improve patient's lives. Raised various financing rounds, recruited board members, created a scientific advisory board, and hired a team to run the programs. Diagnostic tests licensed to Globavir are partnered with Bio-Rad (NASDAQ: BIO) in 2016 and later with Cepheid (now part of Danaher Corporation, NYSE: DHR). Bio-Rad currently sells this technology as part of its RUO (Research Use Only) kits, and Danaher is advancing diagnostic technology through the regulatory approval process worldwide.
-
Founder, Chairman And CeoBiocycive Inc. Sep 2010 - Sep 2015BioCycive was acquired by Sorrento Therapeutics for its oncology programs BC-001 and BC-002 focused on HIF-1 alpha pathway, a group of NCE drug candidates for the treatment of solid cancers. At the time of acquisition, the lead drug was at IND enabling stage. The total deal value of the acquisition was over $160MM including upfront cash, milestones, and royalty. Sorrento then partnered these drugs with NantWorks as part of a joint venture with $100 MM allocated to the development of this program along with two other oncology programs.
-
Board Of DirectorsPhenomenome Discoveries Inc. Oct 2010 - Mar 2015Represent interest of Canadian pension fund on the board.Member of compensation committee. -
Strategy, Genentech CommercialGenentech Mar 2009 - Sep 2010South San Francisco, California, UsCreated strategies to competitively position anti-CD 20 franchise in rheumatoid arthritis both proactively and to assist marketing team in achieving short and long term goals with regard to their tactical and business plans.Coordinated efforts with cross-functional teams (including market planning, finance, competitive intelligence and RA brand teams.) Created and maintained financial models to evaluate impact of strategies on long range forecast and P&L for Genentech’s drugs in rheumatoid arthritis. -
Equity Research, PharmaceuticalsUbs Investment Bank 2007 - 2008Zurich, ChAnalyzed market dynamics and made recommendations regarding growth potential of covered company compounds. Evaluated clinical data presented at several major conferences, including ASCO, ADA, ACC and AHA. Maintained financial models for covered companies, and created therapeutic category models for key medical conditions. Coordinated global efforts with Japanese and European pharmaceutical and biotech teams on key therapeutic categories. Authored preview and review of major medical conferences. Wrote reports analyzing therapeutic categories and market projections. -
Attending PhysicianNyu Medical Center 2004 - 2008New York, Ny, UsWhile working in advisory roles to various healthcare companies and later on as a stock analyst for investment banks, I maintained my clinical practice at NYU on a part time basis. I covered cardiac rehabilitation patients in the inpatient unit, and also saw consults from cardiology, CV surgery, and general medicine services. -
Clinical FacultyNyu Grossman School Of Medicine 2004 - 2008New York, New York, UsDidactic lectures and bedside clinical training to medical students and residents.Mentoring medical students and residents in navigating their professional career. -
Equity Research, BiotechnologyH.C. Wainwright & Co., Llc 2006 - 2007New York, UsBack then, the firm was called Rodman & Renshaw.Built financial models, wrote and published strategic analyses of mid- to large-cap biotechnology companies. Sourced, created and maintained relationships with public companies. Analyzed, synthesized and communicated key information related to covered companies to sales and trading force. -
Medical AdvisorSynageva Biopharma Corp. 2003 - 2004Synageva was known as Avigenics at the time. Help run the first Phase I clinical trial for Avigenic's drug. Responsible for IND filing with the US FDA.
-
AdvisorNyu Langone Medical Center (Office Of Technology Transfer) 2003 - 2004Helped write business plans for new technologies.Helped secure angel round or seed stage VC money for the companies coming out of NYU.Created financial models for new companies.
Shalabh Gupta, Md Skills
Shalabh Gupta, Md Education Details
-
Nyu Grossman School Of MedicineCardiac Rehabilitation -
Nyu Robert F. Wagner Graduate School Of Public ServiceHealth Care Finance And Management
Frequently Asked Questions about Shalabh Gupta, Md
What company does Shalabh Gupta, Md work for?
Shalabh Gupta, Md works for Unicycive Therapeutics
What is Shalabh Gupta, Md's role at the current company?
Shalabh Gupta, Md's current role is Biotech Entrepreneur.
What is Shalabh Gupta, Md's email address?
Shalabh Gupta, Md's email address is do****@****hoo.com
What is Shalabh Gupta, Md's direct phone number?
Shalabh Gupta, Md's direct phone number is +164641*****
What schools did Shalabh Gupta, Md attend?
Shalabh Gupta, Md attended Nyu Grossman School Of Medicine, Nyu Robert F. Wagner Graduate School Of Public Service.
What are some of Shalabh Gupta, Md's interests?
Shalabh Gupta, Md has interest in Children, Economic Empowerment, Education, Science And Technology, Health.
What skills is Shalabh Gupta, Md known for?
Shalabh Gupta, Md has skills like Start Ups, Venture Capital, Biotechnology, Strategy, Entrepreneurship, Lifesciences, Mergers And Acquisitions, Pharmaceutical Industry, Cross Functional Team Leadership, Technology Transfer, Strategic Planning, Clinical Trials.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial